Clincosm LogoSign in Get a demo

Estrogen Receptor Positive

Showing 26 - 37 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Estrogen Receptor Positive, HER2/Neu Negative, Progesterone Receptor Positive Trial (Copanlisib, Fulvestrant, Laboratory

Withdrawn
  • Estrogen Receptor Positive
  • +3 more
  • (no location specified)
Aug 13, 2018

Estrogen Receptor Positive, Invasive Breast Carcinoma, Recurrent Breast Carcinoma Trial in Saint Louis (Akt Inhibitor MK2206,

Completed
  • Estrogen Receptor Positive
  • +3 more
  • Akt Inhibitor MK2206
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 20, 2018

Estrogen Receptor Positive, HER2/Neu Negative, Male Breast Carcinoma Trial in Seattle (drug, procedure, other)

Completed
Has Results
  • Estrogen Receptor Positive
  • +9 more
  • Fluorothymidine F-18
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 13, 2018

Estrogen Receptor Positive, HER2/Neu Negative, Recurrent Breast Carcinoma Trial in United States (drug, other, procedure)

Terminated
Has Results
  • Estrogen Receptor Positive
  • +7 more
  • Akt Inhibitor MK2206
  • +6 more
  • Scottsdale, Arizona
  • +7 more
Apr 6, 2018

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Estrogen Receptor Negative Trial in Bronx, Columbus (drug, other, procedure)

Completed
  • BRCA1 Gene Mutation
  • +11 more
  • Bronx, New York
  • +2 more
Apr 20, 2018

Estrogen Receptor Positive, Male Breast Carcinoma, Progesterone Receptor Positive Trial in Detroit (Laboratory Biomarker

Completed
Has Results
  • Estrogen Receptor Positive
  • +6 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Detroit, Michigan
  • +1 more
Oct 27, 2017

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in New York, The Bronx (drug, procedure, other)

Terminated
Has Results
  • Estrogen Receptor Negative
  • +13 more
  • Akt Inhibitor MK2206
  • +3 more
  • New York, New York
  • +2 more
Aug 1, 2017

Ductal Breast Carcinoma In Situ, Estrogen Receptor Negative, Estrogen Receptor Positive Trial in Buffalo (procedure, radiation,

Terminated
Has Results
  • Ductal Breast Carcinoma In Situ
  • +14 more
  • Therapeutic Conventional Surgery
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jun 7, 2017

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Positive Trial in United States (Akt Inhibitor MK2206,

Terminated
  • Estrogen Receptor Negative
  • +6 more
  • Akt Inhibitor MK2206
  • +4 more
  • New Haven, Connecticut
  • +4 more
Aug 26, 2015

Adult Solid Tumor, Estrogen Receptor Negative, Estrogen Receptor Positive Trial in Hershey, Pittsburgh (Carboplatin, Laboratory

Completed
  • Adult Solid Neoplasm
  • +10 more
  • Hershey, Pennsylvania
  • +2 more
May 22, 2015

Estrogen Receptor Positive, HER2/Neu Negative, Male Breast Carcinoma Trial in United States (Exemestane, Gamma-Secretase

Terminated
  • Estrogen Receptor Positive
  • +6 more
  • Tampa, Florida
  • +3 more
May 22, 2015